Evaluation of efficacy and safety of 2 Sertaconazole nitrate cream in the treatment of tinea corporis & cruris and tinea pedis
Aiping Wang
Abstract
Aiping Wang
Abstract
Objective To compare the efficacy and safety of Sertaconazole nitrate 2 cream and miconazole nitrate 2 cream in the treatment of tinea pedis and tinea corporis cruris.Methods A multi-center,double-blind, randomized controlled trial was conducted. Sertaconazole nitrate 2 cream and miconazole nitrate 2 cream were applied in the trial and control group respectively twice daily for 4 weeks. Patients were evaluated at 0(baseline),2,4,6 weeks.Results Sixty-one cases in the trial group and 58 cases in control group were evaluated for tinea pedis; 56 cases in the trial group and 55 cases in the control group evaluated for tinea corporis cruris.The clinical effective rates for tinea pedis at week 4 were 98.36 in the trial group and 93.10 in control group; and 100 versus 98.28 at week 6 respectively. Mycological cure rates for tinea pedis at week 4 and week 6 were both 95.1 in the trial group and both 100 in the control group. The total effective rates for tinea pedis at week 4 were 98.36 in the trial group and 93.10 in control group; and 100 versus 98.28 at week 6, respectively.The clinical effective rate for tinea corporis cruris at week 4 was 98.21 in the trial group and 92.73 in control group; and 100 versus 98.18 at week 6 respectively. Mycological cure rates for tinea corporis cruris at week 4 and week 6 were all 100 in the trial group and in the control group. The total effective rates for tinea corporis cruris at week 4 were 98.21 in the trial group and 92.73 in control group; and 100 versus 98.18 at week 6, respectively. Treatment-related adverse events consisted of local irritation, occurred in 1.7 of patients in the trial group, 0.9 in the control group. The effcacy and safety of sertaconazole nitrate 2 cream in the treatment of tinea pedis and tinea corporis cruris are similar to that of 2 miconazole nitrate cream(P0.05).Conclusion This study suggests that Sertaconazole nitrate 2 cream was effective and safe in the treatment of tinea pedis and tinea corporis cruris.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To compare the efficacy and safety of Sertaconazole nitrate 2 cream and miconazole nitrate 2 cream in the treatment of tinea pedis and tinea corporis cruris.Methods A multi-center,double-blind, randomized controlled trial was conducted. Sertaconazole nitrate 2 cream and miconazole nitrate 2 cream were applied in the trial and control group respectively twice daily for 4 weeks. Patients were evaluated at 0(baseline),2,4,6 weeks.Results Sixty-one cases in the trial group and 58 cases in control group were evaluated for tinea pedis; 56 cases in the trial group and 55 cases in the control group evaluated for tinea corporis cruris.The clinical effective rates for tinea pedis at week 4 were 98.36 in the trial group and 93.10 in control group; and 100 versus 98.28 at week 6 respectively. Mycological cure rates for tinea pedis at week 4 and week 6 were both 95.1 in the trial group and both 100 in the control group. The total effective rates for tinea pedis at week 4 were 98.36 in the trial group and 93.10 in control group; and 100 versus 98.28 at week 6, respectively.The clinical effective rate for tinea corporis cruris at week 4 was 98.21 in the trial group and 92.73 in control group; and 100 versus 98.18 at week 6 respectively. Mycological cure rates for tinea corporis cruris at week 4 and week 6 were all 100 in the trial group and in the control group. The total effective rates for tinea corporis cruris at week 4 were 98.21 in the trial group and 92.73 in control group; and 100 versus 98.18 at week 6, respectively. Treatment-related adverse events consisted of local irritation, occurred in 1.7 of patients in the trial group, 0.9 in the control group. The effcacy and safety of sertaconazole nitrate 2 cream in the treatment of tinea pedis and tinea corporis cruris are similar to that of 2 miconazole nitrate cream(P0.05).Conclusion This study suggests that Sertaconazole nitrate 2 cream was effective and safe in the treatment of tinea pedis and tinea corporis cruris.
Key concepts: Medicine, Miconazole Nitrate, Tinea capitis, Dermatology, Randomized controlled trial, Miconazole, Dermatophyte, Clinical trial